Clinical Trial Update: Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES): [NA]

View source ↗

Summary

The clinical trial NCT02027272 studying eclampsia and posterior reversible encephalopathy syndrome (PRES) was terminated and results were posted in May 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eclampsia
• Posterior Reversible Encephalopathy Syndrome

Snippet

Sponsor: University of Mississippi Medical Center | Conditions: Eclampsia | NA | Status: TERMINATED | Results posted: 2016-05-26